![]() |
市場調査レポート
商品コード
1593524
細胞分離の市場規模・シェア・成長分析 (製品別、細胞の種類別、細胞供給源別、技術別、用途別、地域別):産業予測 (2024~2031年)Cell Isolation Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source, By Technique, By Application, By Region - Industry Forecast 2024-2031 |
||||||
|
細胞分離の市場規模・シェア・成長分析 (製品別、細胞の種類別、細胞供給源別、技術別、用途別、地域別):産業予測 (2024~2031年) |
出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 188 Pages
納期: 3~5営業日
|
世界の細胞分離の市場規模は、2022年に42億米ドルと評価され、2023年の47億4,000万米ドルから2031年には124億2,000万米ドルに拡大し、予測期間中 (2024~2031年) に12.80%のCAGRで成長する見通しです。
世界の細胞分離市場は、生物製剤開発、治療用タンパク質合成、内部分析、研究などの用途における重要な役割によって、力強い成長を遂げています。がんやCOVID-19のような慢性疾患の有病率の上昇と費用の増加は、バイオテクノロジーを強化する政府のイニシアチブと相まって、主要な成長決定要因となっています。NanoString Technologies、Levitas Bio、Bionano Genomicsのような企業は、製造プロセスを強化し、製品提供を拡大することで、高度な活用領域のための正確な細胞選択を可能にしています。COVID-19パンデミックは、新しい治療や診断補助の研究をさらに加速させ、2020年8月の米国緊急支出法案のようなイニシアチブは、細胞分離機器の需要を後押ししています。 特殊医薬品とジェネリック医薬品が飛躍的に拡大するにつれて、バイオ医薬品への依存度の上昇が市場を活性化させます。
Global Cell Isolation Market size was valued at USD 4.2 billion in 2022 and is poised to grow from USD 4.74 billion in 2023 to USD 12.42 billion by 2031, growing at a CAGR of 12.80% during the forecast period (2024-2031).
The global cell isolation market is witnessing robust growth driven by its critical role in applications such as biologics development, therapeutic protein synthesis, internal analysis, and research. Rising prevalence and costs of chronic diseases like cancer and COVID-19, coupled with government initiatives to bolster biotechnology, are key growth determinants. Companies like NanoString Technologies, Levitas Bio, and Bionano Genomics are enhancing their manufacturing processes and expanding product offerings, enabling precise cell selection for advanced applications. The COVID-19 pandemic further accelerated research in new treatment and diagnostic aids, with initiatives like the U.S. emergency spending bill of August 2020 boosting demand for cell isolation equipment. Growing reliance on biopharmaceuticals fuels the market as specialty and generic medicines expand exponentially.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Isolation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cell Isolation Market Segmental Analysis
Global Cell Isolation Market is segmented by Product, Cell Type, Cell Source, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, and Animal Cells. Based on Cell Source, the market is segmented into Adipose Tissue, Bone Marrow, Cord Blood/Embryonic Stem Cells, and Other Cell Sources. Based on Technique, the market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, and Filtration-Based Cell Isolation. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue, Regeneration & Regenerative Medicine, In Vitro Diagnostics, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Cell Isolation Market
One of the key drivers of the global cell isolation market is the rising prevalence of chronic diseases, particularly cancer. As cancer cases surge globally, there is a growing demand for advanced research and treatment solutions. Cell isolation plays a pivotal role in cancer research by enabling the study of specific cell types, facilitating the development of targeted therapies and personalized medicine. Isolated cells provide critical insights into tumor biology, drug resistance, and immune responses, driving the creation of more effective treatments. Additionally, the increasing adoption of advanced therapies, such as immunotherapy, further boosts the demand for cell isolation techniques. This trend underscores the importance of innovation in the cell isolation market, as research institutes and biotech firms intensify their efforts to combat chronic diseases.
Restraints in the Global Cell Isolation Market
A significant restraint in the global cell isolation market is the high cost of specialized equipment and technologies required for isolating specific cell types. Advanced tools such as flow cytometers, centrifuges, and magnetic-activated cell sorting (MACS) systems are costly, limiting access, particularly for smaller research institutions and laboratories. Additionally, the ongoing expenses related to reagents, as well as the need for highly skilled personnel to operate the equipment, further elevate the financial burden. These factors may restrict the widespread adoption and utilization of advanced cell isolation techniques, particularly in regions with limited financial resources or budget constraints.
Market Trends of the Global Cell Isolation Market
A key trend shaping the global cell isolation market is the growing adoption of microfluidics technology. This innovative approach utilizes small quantities of fluids through microchannels to precisely separate cells based on characteristics such as length, shape, and other biological properties. Microfluidics is gaining significant traction for its ability to efficiently isolate rare cells, such as circulating tumor cells (CTCs) and stem cells, from complex biological samples. Its enhanced precision and performance, coupled with cost-effective processing that minimizes reagent usage, make it a highly attractive solution for both research and medical applications. As a result, microfluidics is poised to revolutionize cell isolation, offering improved accuracy and efficiency in diverse clinical and research settings.